ES434540A1 - Procedimiento para la obtencion de (l)-1- (4-hidroxifenoxi)-2-hidroxi-3-(isopropilamino)-propano. - Google Patents

Procedimiento para la obtencion de (l)-1- (4-hidroxifenoxi)-2-hidroxi-3-(isopropilamino)-propano.

Info

Publication number
ES434540A1
ES434540A1 ES434540A ES434540A ES434540A1 ES 434540 A1 ES434540 A1 ES 434540A1 ES 434540 A ES434540 A ES 434540A ES 434540 A ES434540 A ES 434540A ES 434540 A1 ES434540 A1 ES 434540A1
Authority
ES
Spain
Prior art keywords
formula
compound
group
hydroxy
isopropylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES434540A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES434540A1 publication Critical patent/ES434540A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
ES434540A 1974-02-08 1975-02-07 Procedimiento para la obtencion de (l)-1- (4-hidroxifenoxi)-2-hidroxi-3-(isopropilamino)-propano. Expired ES434540A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH177374A CH585693A5 (es) 1974-02-08 1974-02-08

Publications (1)

Publication Number Publication Date
ES434540A1 true ES434540A1 (es) 1976-12-16

Family

ID=4218257

Family Applications (1)

Application Number Title Priority Date Filing Date
ES434540A Expired ES434540A1 (es) 1974-02-08 1975-02-07 Procedimiento para la obtencion de (l)-1- (4-hidroxifenoxi)-2-hidroxi-3-(isopropilamino)-propano.

Country Status (22)

Country Link
JP (2) JPS6044292B2 (es)
AT (1) AT334880B (es)
BE (1) BE825289A (es)
CA (1) CA1053705A (es)
CH (1) CH585693A5 (es)
CS (1) CS199571B2 (es)
DE (1) DE2503751C2 (es)
DK (1) DK135800B (es)
ES (1) ES434540A1 (es)
FR (1) FR2260337B1 (es)
GB (1) GB1470039A (es)
HK (1) HK87279A (es)
HU (1) HU174113B (es)
IE (1) IE40590B1 (es)
IL (1) IL46592A (es)
KE (1) KE3007A (es)
MX (1) MX3831E (es)
MY (1) MY8000199A (es)
NL (1) NL7501496A (es)
SE (1) SE412905B (es)
YU (5) YU39313B (es)
ZA (1) ZA75799B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4202978A (en) * 1978-02-08 1980-05-13 Hoffmann-La Roche Inc. (S)-1-[2-(4-(2-Hydroxy-s-(1-alkylaminopropoxy)phenylalkyl]-4-phenylpiperazines
US4294966A (en) * 1978-07-28 1981-10-13 Ciba-Geigy Corporation Process for inverting the configuration in optically active compounds
GB2119366B (en) * 1979-03-01 1984-04-11 Siemens Spa Italiana The levorotatory isomer of moprolol and pharmaceutical compositions thereof
JPH0419666Y2 (es) * 1985-09-30 1992-05-06
JPS62150579A (ja) * 1985-12-25 1987-07-04 Matsushita Electric Ind Co Ltd ラジオ受信機付カセツトテ−プレコ−ダ
ZA991319B (en) 1998-02-20 2000-11-20 Ortho Mcneil Pharm Inc Novel phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL301580A (es) * 1962-12-11
GB1136919A (en) * 1965-06-16 1968-12-18 Ici Ltd Amines
CH509265A (de) * 1967-01-04 1971-06-30 Spofa Vereinigte Pharma Werke Verfahren zur Herstellung von neuen Trimethylhydrochinonderivaten
SE372762B (es) * 1969-05-21 1975-01-13 Haessle Ab
ZA732136B (en) * 1972-04-12 1974-03-27 Lilly Co Eli Dopamine derivatives

Also Published As

Publication number Publication date
HU174113B (hu) 1979-11-28
CH585693A5 (es) 1977-03-15
IE40590L (en) 1975-08-08
IL46592A0 (en) 1975-04-25
DK645474A (es) 1975-09-29
YU39313B (en) 1984-10-31
NL7501496A (nl) 1975-08-12
ATA90275A (de) 1976-06-15
SE412905B (sv) 1980-03-24
YU27075A (en) 1982-06-30
DE2503751A1 (de) 1975-08-14
MY8000199A (en) 1980-12-31
YU123681A (en) 1982-06-30
YU123781A (en) 1982-06-30
DK135800B (da) 1977-06-27
FR2260337B1 (es) 1978-07-21
HK87279A (en) 1979-12-28
BE825289A (fr) 1975-08-07
CA1053705A (en) 1979-05-01
IE40590B1 (en) 1979-07-04
YU123481A (en) 1984-10-31
YU123581A (en) 1982-06-30
DE2503751C2 (de) 1986-05-22
GB1470039A (en) 1977-04-14
AU7795475A (en) 1976-08-12
ZA75799B (en) 1976-01-28
FR2260337A1 (es) 1975-09-05
IL46592A (en) 1978-03-10
CS199571B2 (en) 1980-07-31
SE7500205L (es) 1975-08-09
JPS50108228A (es) 1975-08-26
KE3007A (en) 1979-12-14
JPS6044292B2 (ja) 1985-10-02
JPS6064951A (ja) 1985-04-13
AT334880B (de) 1977-02-10
YU39267B (en) 1984-10-31
MX3831E (es) 1981-08-04
DK135800C (es) 1977-12-12

Similar Documents

Publication Publication Date Title
ES434540A1 (es) Procedimiento para la obtencion de (l)-1- (4-hidroxifenoxi)-2-hidroxi-3-(isopropilamino)-propano.
ES392480A1 (es) Procedimiento para la preparacion de difenil-imidazoles.
ES428375A1 (es) Un procedimiento para preparar piperidinas disustituidas enlas posiciones 1 y 4.
ES394562A1 (es) Un procedimiento para la preparacion de nuevos imidazoles.
ES404744A1 (es) Un procedimiento para producir derivados de cefalosporina.
ES438364A1 (es) Procedimiento para la obtencion de nuevos derivados de gen- tamicina.
ES431724A1 (es) Procedimiento para preparar derivados de eritrodiol.
ES325827A1 (es) Procedimiento para producir compuestos de 2-fenoxi-2-fenilacetamida.
ES395534A1 (es) Procedimiento para preparar compuestos esteroides insatura-dos en la posicion 9 (11) yno 17.
ES288799A1 (es) Procedimiento para preparar nuevos quelatos metálicos con grupos epóxidos
ES420140A1 (es) Un procedimiento para preparar compuestos de acido tetrahi-dro-indazol-5-carboxilico.
ES381618A1 (es) Un metodo de producir nuevas fenilcarbamoiloxazolidinas.
ES438481A1 (es) Procedimiento para la obtencion de derivados de triazol.
ES434550A2 (es) Procedimiento para la obtencion de 1-fenoxi-2-hidroxi-3-ami-no-propanos.
ES422607A1 (es) Un procedimiento para la preparacion de 13-etil-3-metoxi-8, 14-seco-gona-1,3,5(10), 8-tetraeno-17 beta-ol-14-ona racemi-ca.
ES390168A1 (es) Un procedimiento para producir ester dicilico de la pros- taglandina a2.
ES387840A1 (es) Procedimiento para la produccion de derivados de acetanili-da.
ES428011A1 (es) Procedimiento para la preparacion de 2-amino-3,5-dibromo- bencilamina.
ES385062A1 (es) Procedimiento de preparacion de derivados de 1-amino-3-fe- noxi-2-propanol.
ES439066A1 (es) Procedimiento para la obtencion de sales alcalinas del acido4-hidroxibutirico.
ES438467A1 (es) Procedimiento para preparar derivados bencimidazol 1, 2-bi- substituidos.
ES429697A1 (es) Un procedimiento para la preparacion de un derivado de aze-tidinol.
ES420471A1 (es) Un procedimiento para la produccion de derivados sustituidosde acido fenoxi-alfa-metilpropionico.
ES426755A1 (es) Un procedimiento de preparacion del ester mixto 1 - 2 - (p-clorofenoxi) - 2 - metilpropianoato, 2 - nicotinato de eti- lenglicol.
ES422876A1 (es) Procedimiento para la obtencion de derivados del acido prostanico.